S&P Futures
3,750.50 +60.25 (+1.63%) Dow Futures
29,937.00 +399.00 (+1.35%) Nasdaq Futures
11,517.25 +231.50 (+2.05%) Russell 2000 Futures
1,746.80 +31.90 (+1.86%) Crude Oil
84.06 +0.43 (+0.51%) Gold
1,712.10 +10.10 (+0.59%)
Ekso Bionics Holdings, Inc. (EKSO)
After hours:
Chart Events
Performance Outlook
| Previous Close | 1.5600 |
| Open | 1.5500 |
| Bid | 0.0000 x 800 |
| Ask | 0.0000 x 900 |
| Day's Range | 1.5300 - 1.5800 |
| 52 Week Range | 1.4100 - 4.4900 |
| Volume | |
| Avg. Volume | 39,700 |
| Market Cap | 20.009M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.0200 |
| Earnings Date | Oct 31, 2022 - Nov 04, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
Is Ekso Bionics Holdings (NASDAQ:EKSO) Weighed On By Its Debt Load?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
- GlobeNewswire
Ekso Bionics to Present at H.C. Wainwright 24th Annual Global Investment Conference
SAN RAFAEL, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announced that Scott Davis, President and Chief Operating Officer, will be presenting virtually at the H.C. Wainwright 24th Annual Global Investment Conference taking place September 12-14, 2022. The pre-recorded presentation will be available to view on-demand as of 4:00 AM PT / 7:00 AM ET, Monday, S
- Zacks
Ekso Bionics (EKSO) Reports Q2 Loss, Misses Revenue Estimates
Ekso Bionics (EKSO) delivered earnings and revenue surprises of 4.17% and 0.72%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
